Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
ReShape Lifesciences Inc (RSLS)  
$0.12 0.00 (0.00%) as of 4:30 Thu 12/22


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 9,000,000
Market Cap: 1.04(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.1151 - $0.1151
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ReShape Lifesciences is a weight-loss solutions company, providing a portfolio of products and services that manage and treat obesity and associated metabolic disease. Co.'s primary operations are in the following geographical areas: U.S., Australia and certain European and Middle Eastern countries. Co.'s portfolio includes the Lap-Band Adjustable Gastric Banding System, the reshapecare virtual health coaching program, the ReShape Marketplace, the Obalon Balloon System, the ReShape Vest, an investigational device to help treat more patients with obesity, and the Diabetes Bloc-Stim Neuromodulation device, a technology under development as a new treatment for type 2 diabetes mellitus.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 17,702 37,702
Total Buy Value $0 $0 $26,907 $45,329
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 2
Total Shares Sold 0 0 639 443,150
Total Sell Value $0 $0 $777 $106,051
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 7 23
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 139
  Page 6 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Johnson Steven Ernest VP of Operations   •       –      –    2017-04-30 4 A $9.03 $6,745 D/D 747 747     -
   Brister Mark VP of Research and Development   •       –      –    2017-04-30 4 A $9.03 $13,997 D/D 1,550 162,010     -
   Drake Neil VP of Research and Development   •       –      –    2017-02-01 3 IO $0.00 $0 D/D 0 4,520     -
   Halak Brian K 10% Owner   –       –       •   2016-10-12 4 A $0.00 $0 D/D 49,570 49,570     -
   Halak Brian K 10% Owner   –       –       •   2016-10-12 4 A $0.00 $0 D/D 3,985,970 3,985,970     -
   Kamdar Kim P. Director   –       •      –    2016-10-12 4 B $15.00 $201,000 D/D 13,400 13,400 2.39     -
   Norwood Matthew VP of Sales   •       –      –    2016-10-12 4 B $15.00 $15,000 I/I 1,000 1,000 1.99     -
   Nasr Khaled 10% Owner   –       –       •   2016-10-12 4 A $0.00 $0 D/D 2,453,338 2,453,338     -
   Stevenson Sharon Director   –       •      –    2016-10-12 4 A $0.00 $0 I/I 887,468 341,235     -
   Brister Mark VP of Research and Development   •       –      –    2016-10-05 3 IO $0.00 $0 D/D 0 160,460     -
   Plovanic William J. Chief Financial OfficerOfficer   •       –      –    2016-10-05 3 IO $0.00 $0 D/D 0 190,572     -
   Hussainy Nooshin VP of FinanceOfficer   •       –      –    2016-10-05 3 IO $0.00 $0 D/D 0 58,043     -
   Rasdal Andrew P President & CEOOfficer   •       •      –    2016-10-05 3 IO $0.00 $0 I/I 0 450,495     -
   Howe Lesley H Director   –       •      –    2016-10-05 3 IO $0.00 $0 D/D 0 25,862     -

  139 Records found
  1  2  3  4  5  6    
  Page 6 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed